Lily Lyman, managing partner at Underscore VC, discusses how AI will help supercharge discoveries in life sciences and healthcare with the possibility of unlocking $4 trillion in value. She joins Caroline Hyde on "Bloomberg Tech."
Breakdown
- AI is transforming life sciences by enabling data-driven approaches and unlocking significant value. 19s
- The integration of AI could reduce drug development costs and timelines, potentially unlocking $4 trillion across the sector. 1m 0s
- Major pharmaceutical companies are partnering with startups to leverage AI, exemplified by Takeda's collaboration with Tetra Science. 2m 19s
- AI-driven partnerships are resulting in faster workflows and increased productivity for industry players. 2m 19s
- Startups and established AI firms are expected to collaborate, as practical implementation requires both domain expertise and technological innovation. 3m 33s